Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOAS
3026
DELISTED
BOA Acquisition Corp.
BOAS
| $3.81M | ﹤0.01% |
389,289
+59,157
| +18% | +$583K |
|
3027
Viking Therapeutics
VKTX
$4.02B
| $3.8M | ﹤0.01% |
1,314,756
-187,130
| -12% | -$463K |
|
|
CNH
3028
CNH Industrial
CNH
$16.9B
| $3.8M | ﹤0.01% |
327,837
-428,954
| -57% | -$6.11M |
|
3029
Montauk Renewables
MNTK
$243M
| $3.8M | ﹤0.01% |
377,688
-296,586
| -44% | -$3.53M |
|
|
AMRN
3030
Amarin Corp
AMRN
$298M
| $3.79M | ﹤0.01% |
127,341
-116,928
| -48% | -$5.04M |
|
3031
ArcBest
ARCB
$3.07B
| $3.79M | ﹤0.01% |
53,875
+9,944
| +23% | +$731K |
|
|
KSI
3032
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
| $3.79M | ﹤0.01% |
388,790
+1,000
| +0.3% | +$9.76K |
|
3033
Rayonier
RYN
$6.52B
| $3.79M | ﹤0.01% |
111,657
+98,628
| +757% | +$3.61M |
|
|
AVID
3034
DELISTED
Avid Technology Inc
AVID
| $3.79M | ﹤0.01% |
145,912
-663,668
| -82% | -$19.3M |
|
3035
Precigen
PGEN
$2.51B
| $3.78M | ﹤0.01% |
2,824,171
-2,109,264
| -43% | -$3.13M |
|
3036
CALL
iRhythm Holdings
IRTC
$4.1B
| $3.78M | ﹤0.01% |
+35,000
| New | +$4.64M |
|
3037
Illinois Tool Works
ITW
$83.9B
| $3.78M | ﹤0.01% |
20,731
+1,042
| +5% | +$208K |
|
|
GIAC
3038
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
| $3.78M | ﹤0.01% |
383,350
+358,765
| +1,459% | +$3.54M |
|
3039
CTS Corp
CTS
$1.85B
| $3.77M | ﹤0.01% |
+110,780
| New | +$4.01M |
|
3040
CALL
TE Connectivity
TEL
$62B
| $3.77M | ﹤0.01% |
+33,300
| New | +$4.12M |
|
|
CND
3041
DELISTED
Concord Acquisition Corp.
CND
| $3.77M | ﹤0.01% |
378,058
-136,942
| -27% | -$1.36M |
|
3042
Ooma
OOMA
$593M
| $3.76M | ﹤0.01% |
317,809
+156,443
| +97% | +$2.08M |
|
3043
CALL
Global Payments
GPN
$22.8B
| $3.76M | ﹤0.01% |
34,000
| – | – |
|
3044
Kodiak Sciences
KOD
$2.72B
| $3.76M | ﹤0.01% |
492,383
-563,347
| -53% | -$3.96M |
|
3045
PUT
Weyerhaeuser
WY
$18.2B
| $3.76M | ﹤0.01% |
113,600
-43,200
| -28% | -$1.65M |
|
3046
Vera Therapeutics
VERA
$2.27B
| $3.76M | ﹤0.01% |
276,243
+142,743
| +107% | +$2.49M |
|
3047
Granite Construction
GVA
$5.51B
| $3.76M | ﹤0.01% |
128,972
-45,269
| -26% | -$1.41M |
|
3048
Seres Therapeutics
MCRB
$50.2M
| $3.75M | ﹤0.01% |
54,696
+25,232
| +86% | +$2.17M |
|
3049
CALL
Labcorp
LH
$26.1B
| $3.75M | ﹤0.01% |
+18,624
| New | +$3.97M |
|
|
ZINGU
3050
DELISTED
FTAC Zeus Acquisition Corp. Unit
ZINGU
| $3.75M | ﹤0.01% |
374,990
-125,010
| -25% | -$1.25M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.